Ptc Therapeutics (PTCT) Non-cash Items (2013 - 2026)

Ptc Therapeutics' Non-cash Items history runs 11 years deep, the most recent figure standing at $155.4 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 2286.64% year-over-year to $155.4 million; the TTM figure through Mar 2026 stood at $155.4 million (up 2286.64% YoY), while the FY2025 annual figure was $210.7 million, up 230.55% from the prior year.
• Non-cash Items was $155.4 million for Q1 2026 at Ptc Therapeutics, down from $210.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $210.7 million in Q4 2025 to a low of $5.1 million in Q3 2023.
• Historically, Non-cash Items has averaged $56.1 million across 5 years, with a median of $14.2 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Non-cash Items slumped 95.45% in 2023, then jumped 2286.64% in 2026.
• A 5-year view of Non-cash Items shows it stood at $7.8 million in 2022, then rose by 13.37% to $8.8 million in 2023, then surged by 623.16% to $63.7 million in 2024, then soared by 230.55% to $210.7 million in 2025, then dropped by 26.22% to $155.4 million in 2026.
• The last three Non-cash Items figures came in at $155.4 million (Q1 2026), $210.7 million (Q4 2025), and $151.2 million (Q3 2025), per Business Quant data.